

Cover Story
Free
Brigham Doc's NEJM Paper Decries Morcellation's Demise—Did She Get Confidential Patient Information?
By Matthew Bin Han Ong
Update: The New England Journal of Medicine's subsequent response after this article is published is appended at the end.
In Brief


Drugs & Targets
Trending Stories
- As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI - Scaling excellence: How City of Hope is transforming cancer care delivery